PROCEPT BioRobotics (NASDAQ: PRCT) revenue
PROCEPT BioRobotics reported revenue of $308.1m for fiscal 2025, 37.2% more than in fiscal 2024 ($224.5m). Since fiscal 2020 its revenue has grown by 3,891.9%, an average growth of 109.0% a year.
PROCEPT BioRobotics has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 6 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $308.1m | +37.2% | −$103.9m | −33.7% |
| 2024 | $224.5m | +64.8% | −$96.6m | −43.0% |
| 2023 | $136.2m | +81.6% | −$109.2m | −80.2% |
| 2022 | $75.0m | +117.6% | −$80.7m | −107.6% |
| 2021 | $34.5m | +346.7% | −$54.2m | −157.1% |
| 2020 | $7.7m | — | −$47.8m | −619.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
PROCEPT BioRobotics revenue compared with its sector
By revenue for its latest fiscal year, PROCEPT BioRobotics ranks 218th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; PROCEPT BioRobotics, 37.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 216th | AngioDynamics | $320.2m | 9.5% |
| 217th | Cormedix | $311.7m | 617.0% |
| 218th | PROCEPT BioRobotics | $308.1m | 37.2% |
| 219th | Healthstream | $304.1m | 4.3% |
| 220th | Evolus | $297.2m | 11.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of PROCEPT BioRobotics
- How much revenue did PROCEPT BioRobotics make in fiscal 2025?
- PROCEPT BioRobotics reported revenue of $308.1m for fiscal 2025, compared with $224.5m in fiscal 2024.
- How much has the revenue of PROCEPT BioRobotics grown?
- Between fiscal 2020 and fiscal 2025 it went from $7.7m to $308.1m: 3,891.9% more, an average growth of 109.0% a year.
- What was the best year for revenue at PROCEPT BioRobotics?
- Of its last 6 fiscal years, fiscal 2025, with $308.1m.
- Where does PROCEPT BioRobotics rank in its sector by revenue?
- It ranks 218th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for PROCEPT BioRobotics come from?
- From the annual report (Form 10-K) that PROCEPT BioRobotics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that PROCEPT BioRobotics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on PROCEPT BioRobotics: the PROCEPT BioRobotics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.